Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling
M. Phillip DeYoung(Johnson & Johnson (United States)), Leif W. Ellisen(Harvard University)
Cited by 696
Related Papers
Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
|Journal of Clinical Oncology|2010|983
PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition
|Cancer Discovery|2012|622
Induction of GADD45 and JNK/SAPK-Dependent Apoptosis following Inducible Expression of BRCA1
|Cell|1999|559
Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq
|Nature Communications|2018|509